TriSalus Life Sciences, Inc. Stock Analysis & AI Score
TriSalus Life Sciences, Inc. (TLSI) has an ST Score of 46.1 (C+), driven by its Forecast (A) and held back by its Growth (C-). Analysts rate it Buy with a $11.00 price target (+138.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
TriSalus Life Sciences, Inc. (TLSI) has an ST Score of 46.1 (C+), driven by its Forecast (A) and held back by its Growth (C-). Analysts rate it Buy with a $11.00 price target (+138.6% upside).
- Strongest
- ForecastA
- Weakest
- GrowthC-
All factor grades
- ForecastA
- MomentumA-
- ValuationC
- Financial StrengthC
- ProfitabilityC-
- GrowthC-
- Piotroski2/9
Contact
TLSI stock: frequently asked questions
What is TLSI's ST Score?
TriSalus Life Sciences, Inc. (TLSI) has an ST Score of 46.1 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is TLSI a buy, hold, or sell?
Analysts rate TLSI a Buy, with a price target of $11.00 (+138.6% vs the current price). Our ST Score grades it C+ (46.1/100). The ST Score is a data-driven signal, not a recommendation.
What are TLSI's factor grades?
Valuation C, Profitability C-, Financial Strength C, Momentum A-, Growth C-, Forecast A.
What is TLSI's valuation grade?
TriSalus Life Sciences, Inc. (TLSI) earns a valuation grade of C, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is TLSI's growth grade?
TriSalus Life Sciences, Inc. (TLSI) earns a growth grade of C-, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is TLSI's profitability grade?
TriSalus Life Sciences, Inc. (TLSI) earns a profitability grade of C-, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is TLSI's financial strength grade?
TriSalus Life Sciences, Inc. (TLSI) earns a financial strength grade of C, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for TLSI?
The average analyst price target for TriSalus Life Sciences, Inc. (TLSI) is $11.00 from 4 analysts, which is +138.6% versus the recent price of $4.61.
What is TLSI's Piotroski score?
TriSalus Life Sciences, Inc. (TLSI) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.